News Archive


The healthcare sector is one of the most heavily regulated sectors in many countries. Following a number of major scandals in the twentieth century such as the thalidomide disaster in the 1960s, wide-ranging regulation has been implemented in health systems to ensure that medicines are safe to use, healthcare professionals are adequately trained, and health...
Corruption has become prevalent in healthcare to the point that it is normalised. From the politician to the patient, individuals routinely place their own private interests above public health goals and patient health outcomes. That was the conclusion from speaking to thirty healthcare experts and anti-corruption specialists across the globe, as part of our most...
20th September 2016, London – Transparency International Pharmaceuticals & Healthcare Programme (TI-PHP) welcomes news that NHS doctors will be required to declare income from private work. Under the new rules, every hospital will be made to publish a register of consultants’ outside earnings from April to expose potential conflicts of interest. Sophie Peresson, TI-PHP Director,...
London, 15th September 2016 – Transparency International Pharmaceuticals and Healthcare Programme (TI-PHP) welcomes the publication of a new report from the UN that views transparency in healthcare “as a core component” in improving the global access to medicines. The UN report of the Secretary-Generals High-Level Panel on Access to Medicines places emphasis on governance, accountability and transparency to guarantee that medical products...
Corruption within the pharmaceutical and healthcare sectors is a matter of life and death. It has a corrosive impact on health, negatively impacting public health budgets, the price of health services and medicines, and ultimately the quality of care dispensed. Reports estimate that as much as 6% of annual global health expenditure is lost to corruption...
Governments and companies refusing to take corruption seriously London, 2nd June 2016 – The global pharmaceutical sector is wide open to corruption abuse, with both governments and companies failing to properly address corruption risks, according to new research from Transparency International (TI) Pharmaceuticals & Healthcare Programme. As of the beginning of 2016, 1 in 10...
Procurement in health involves the purchase of products, supplies, equipment and related services, as well as the commissioning of the construction of health facilities. For medicines this comes after a product has been selected for inclusion on a national reimbursement list and/or a health facility list. This is a considerable expense in most health budgets,...

The Pharmaceuticals & Healthcare Programme is an international programme of Transparency International, based in the London office of Transparency International UK.

Contact Us